Eramol
Peter Mollison is an experienced professional in the pharmaceutical industry, currently serving as COO and Co-Founder of Eramol since 2015. Previously, Peter held consultancy roles as a Qualified Person at A NELSON & CO LIMITED and served as Quality Director at both RENASCIENCE PHARMA LIMITED and RenaClinical, where responsibilities included quality operations, designing and maintaining Quality Management Systems (QMS), and certification of commercial and investigational medicinal products. Additional experience includes strategic leadership in commercialization projects at St George's University Hospitals NHS Foundation Trust and a progression from deputy management to quality assurance roles at various NHS trusts. Peter's educational background includes a Master of Pharmacy from The University of Manchester and ongoing studies at the University of Strathclyde.
This person is not in any teams
This person is not in any offices
Eramol
1 followers
Eramol provides a bespoke clinical trial manufacturing service, driven by transparency, delivery, and innovation. Founded in the UK by two Qualified Persons, Eramol is renowned for offering high quality, end-to-end manufacturing and global distribution services for clinical trials for commercial and non-commercial clients across the globe. A full-service operation that has been created to meet your needs, Eramol provides a one-stop-shop for clinical trial supply service. Covering the full spectrum and catering for both small- and large-scale batch manufacturing in our state-of-the-art MHRA and HPRA approved facilities. Every step of Eramol’s comprehensive and dedicated clinical service is the result of specialist industry knowledge and over 30 years’ innovation in the pharmacological development sector.